title: Gender specific effects on the actin-remodelling protein Flightless I and TGF-beta1 contribute to impaired wound healing in aged skin.
abstract: Impaired wound healing in the elderly presents a major clinical challenge. Understanding the cellular mechanisms behind age-related impaired healing is vital for developing new wound therapies. Here we show that the actin-remodelling protein, Flightless I (FliI) is a contributing factor to the poor healing observed in elderly skin and that gender plays a major role in this process. Using young and aged, wild-type and FliI overexpressing mice we found that aging significantly elevated FliI expression in the epidermis and wound matrix. Aging exacerbated the negative effect of FliI on wound repair and wounds in aged FliI transgenic mice were larger with delayed reepithelialisation. When the effect of gender was further analysed, despite increased FliI expression in young and aged male and female mice, female FliI transgenic mice had the most severe wound healing phenotype suggesting that male mice were refractory to FliI gene expression. Of potential importance, males, but not females, up-regulated transforming growth factor-beta1 and this was most pronounced in aged male FliI overexpressing wounds. As FliI also functions as a co-activator of the estrogen nuclear receptor, increasing concentrations of beta-estradiol were added to skin fibroblasts and keratinocytes and significantly enhanced FliI expression and translocation of FliI from the cytoplasm to the nucleus was observed. FliI further inhibited estrogen-mediated collagen I secretion suggesting a mechanism via which FliI may directly affect provisional matrix synthesis. In summary, FliI is a contributing factor to impaired healing and strategies aimed at decreasing FliI levels in elderly skin may improve wound repair.
authors.affiliation: Women's and Children's Health Research Institute, 72 King William Road, North Adelaide, SA, Australia.
authors.forename: Damian H
authors.initials: DH
authors.lastname: Adams
authors.forename: Xanthe L
authors.initials: XL
authors.lastname: Strudwick
authors.forename: Zlatko
authors.initials: Z
authors.lastname: Kopecki
authors.forename: Jane A
authors.initials: JA
authors.lastname: Hooper-Jones
authors.forename: Klaus I
authors.initials: KI
authors.lastname: Matthaei
authors.forename: Hugh D
authors.initials: HD
authors.lastname: Campbell
authors.forename: Barry C
authors.initials: BC
authors.lastname: Powell
authors.forename: Allison J
authors.initials: AJ
authors.lastname: Cowin
mesh_terms: D000375:Aging / Q000502:physiology*; D000818:Animals; D002352:Carrier Proteins; D002467:Cell Nucleus / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000096:biosynthesis / Q000502:physiology*; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008840:Microfilament Proteins; D021381:Protein Transport; D012737:Sex Factors; D015534:Trans-Activators; D053773:Transforming Growth Factor beta1 / Q000502:physiology*; D015854:Up-Regulation; D014945:Wound Healing / Q000502:physiology*
chemical_list: D002352:Carrier Proteins; D003598:Cytoskeletal Proteins; C000609263:FlII protein, mouse; D008840:Microfilament Proteins; D015534:Trans-Activators; D053773:Transforming Growth Factor beta1; D004958:Estradiol